AXIAL SPONDYLARTHRITIS (R-AXSPA)
Clinical trials for AXIAL SPONDYLARTHRITIS (R-AXSPA) explained in plain language.
Never miss a new study
Get alerted when new AXIAL SPONDYLARTHRITIS (R-AXSPA) trials appear
Sign up with your email to follow new studies for AXIAL SPONDYLARTHRITIS (R-AXSPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World study tests upadacitinib for back pain in axial spondyloarthritis
Disease control OngoingThis study looks at how well upadacitinib (RINVOQ) works for people with axial spondyloarthritis, a type of inflammatory arthritis that causes chronic back pain. About 338 adults in Germany will take the drug as prescribed by their doctor and be followed for 52 weeks. Researchers…
Matched conditions: AXIAL SPONDYLARTHRITIS (R-AXSPA)
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Digital diary aims to decode painful flares in spine condition
Knowledge-focused OngoingThis study investigates how people with axial spondyloarthritis (axSpA) experience sudden worsening of symptoms, known as flares. Over 12 months, 40 participants use a digital diary to track symptoms, diet, lifestyle, and self-management strategies, and provide blood samples duri…
Matched conditions: AXIAL SPONDYLARTHRITIS (R-AXSPA)
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC